Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1989 1
1995 1
1997 1
1999 1
2000 1
2002 4
2004 2
2005 5
2006 1
2007 2
2008 3
2010 3
2011 4
2012 3
2013 2
2014 6
2015 2
2016 2
2017 9
2018 1
2019 5
2020 11
2021 9
2022 22
2023 40
2024 41
2025 42

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

201 results

Results by year

Filters applied: . Clear all
Page 1
Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study.
Avallone G, Mastorino L, Tavoletti G, Macagno N, Barei F, Schena D, Rossi M, Magnaterra E, Antonelli F, Babino G, Viola R, Gargiulo L, Conforti C, Rapparini L, Errichetti E, Patruno C, Ruggiero P, Roccuzzo G, Maronese CA, Girolomoni G, Gola M, Chiricozzi A, Balato A, Ambrogio F, Narcisi A, Zalaudek I, Gurioli C, Napolitano M, Marzano AV, Foti C, Costanzo A, Piraccini BM, Ferrucci SM, Ortoncelli M, Quaglino P, Ribero S. Avallone G, et al. Among authors: gargiulo l. J Am Acad Dermatol. 2024 May;90(5):1031-1034. doi: 10.1016/j.jaad.2024.01.004. Epub 2024 Jan 9. J Am Acad Dermatol. 2024. PMID: 38199282 No abstract available.
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis).
Gargiulo L, Ibba L, Malagoli P, Balato A, Bardazzi F, Burlando M, Carrera CG, Damiani G, Dapavo P, Dini V, Gaiani FM, Girolomoni G, Guarneri C, Lasagni C, Loconsole F, Marzano AV, Megna M, Mercuri SR, Travaglini M, Costanzo A, Narcisi A. Gargiulo L, et al. Front Immunol. 2024 Jan 11;14:1341708. doi: 10.3389/fimmu.2023.1341708. eCollection 2023. Front Immunol. 2024. PMID: 38274801 Free PMC article.
Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus.
Gargiulo L, Ibba L, Malagoli P, Burroni AG, Chiricozzi A, Dapavo P, Ferrucci SM, Gola M, Napolitano M, Ortoncelli M, Rossi MT, Sciarrone C, Costanzo A, Narcisi A. Gargiulo L, et al. Dermatol Ther (Heidelb). 2024 Apr;14(4):919-932. doi: 10.1007/s13555-024-01135-x. Epub 2024 Mar 21. Dermatol Ther (Heidelb). 2024. PMID: 38509380 Free PMC article.
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study.
Campione E, Artosi F, Shumak RG, Giunta A, Argenziano G, Assorgi C, Balato A, Bernardini N, Brunasso AMG, Burlando M, Caldarola G, Campanati A, Carugno A, Castelli F, Conti A, Costanzo A, Cuccia A, Dapavo P, Dattola A, De Simone C, Di Lernia V, Dini V, Donini M, Errichetti E, Esposito M, Fargnoli MC, Foti A, Fiorella C, Gargiulo L, Gisondi P, Guarneri C, Legori A, Lembo S, Loconsole F, Malagoli P, Marzano AV, Mercuri SR, Megna M, Micali G, Mortato E, Musumeci ML, Narcisi A, Offidani AM, Orsini D, Paolino G, Pellacani G, Peris K, Potenza C, Prignano F, Quaglino P, Ribero S, Richetta AG, Romanelli M, Rossi A, Strippoli D, Trovato E, Venturini M, Bianchi L. Campione E, et al. Among authors: gargiulo l. Pharmaceuticals (Basel). 2024 Oct 16;17(10):1378. doi: 10.3390/ph17101378. Pharmaceuticals (Basel). 2024. PMID: 39459016 Free PMC article.
Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study.
Gargiulo L, Ferrucci SM, Ibba L, Ingurgio RC, Alfano A, Amoruso GF, Balato A, Barbagallo T, Barei F, Bellinato F, Brianti P, Burroni AG, Campanati A, Caroppo F, Carugno A, Bello GD, De Franco F, Fortina AB, Foti C, Gaiani FM, Girolomoni G, Gola M, Guanti MB, Gurioli C, Legori A, Loconsole F, Magnaterra E, Malagoli P, Margiotta FM, Marzano AV, Mercuri SR, Milanesi N, Musumeci ML, Napolitano M, Ortoncelli M, Paolino G, Patruno C, Pella P, Pezzolo E, Prestinari F, Recalcati S, Ribero S, Rongioletti F, Rossi M, Satolli F, Savoia P, Sciarrone C, Spigariolo C, Stabile G, Tirone B, Tolino E, Zerbinati N, Potenza C, Costanzo A, Narcisi A. Gargiulo L, et al. J Eur Acad Dermatol Venereol. 2025 Sep;39(9):e807-e811. doi: 10.1111/jdv.20699. Epub 2025 Apr 17. J Eur Acad Dermatol Venereol. 2025. PMID: 40247595 No abstract available.
Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort Study.
Avallone G, Maronese CA, Zussino M, Muratori S, Ferrucci SM, Quaglino P, Manni E, Romanelli M, De Simone C, Foti C, Gargiulo L, Maione V, Calzavara-Pinton P, Bardazzi F, Piraccini BM, Antiga E, Rech G, Balestri R, Vezzoli P, Sena P, Esposito M, Fargnoli MC, Termini D, Valtellini L, Satta RR, Vassallo C, Provini A, Di Zenzo G, Campanati A, Caproni M, Cozzani E, Ribero S, Marzano AV; DUO—DUpilumab and Omalizumab in Bullous Pemphigoid Study Group. Avallone G, et al. Among authors: gargiulo l. J Dermatol. 2025 Jun;52(6):983-1000. doi: 10.1111/1346-8138.17742. Epub 2025 Apr 16. J Dermatol. 2025. PMID: 40237419
Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study.
Vignoli CA, Gargiulo L, Ibba L, Balato A, Barbareschi M, Barruscotti S, Bazzacco G, Bellinato F, Bianchi VG, Boccaletti V, Caposiena Caro RD, Ferrucci SM, Fraghì A, Fulgione E, Gallo G, Gisondi P, Giunipero di Corteranzo I, Malagoli P, Marzano AV, Mercuri SR, Orsini D, Quaglino P, Ribero S, Costanzo A, Narcisi A. Vignoli CA, et al. Among authors: gargiulo l. J Dermatolog Treat. 2025 Dec;36(1):2444494. doi: 10.1080/09546634.2024.2444494. Epub 2025 Jan 6. J Dermatolog Treat. 2025. PMID: 39761973 Free article.
Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularis.
Avallone G, Bombelli A, Valtellini L, Tavoletti G, Galli B, Rossi M, Maurelli M, Girolomoni G, Gargiulo L, Narcisi A, di Vico F, Napolitano M, Lazzeri L, Calabrese L, Caccavale S, Balato A, Barei F, Calzari P, Foti C, Trave I, Cozzani E, Rongioletti F, Lenti S, Gurioli C, Nettis E, Caroppo F, Errichetti E, Bonzano L, Gori N, Peris K, Lembo S, Del Regno L, Esposito M, Fargnoli MC, Savoia P, Esposto E, Giuffrida R, Guarneri F, Patruno C, Pezzolo E, Stingeni L, Hansel K, Mastorino L, Ortoncelli M, Ribero S, Marzano AV, Ferrucci SM. Avallone G, et al. Among authors: gargiulo l. Clin Exp Dermatol. 2025 Oct 27;50(11):2211-2220. doi: 10.1093/ced/llaf302. Clin Exp Dermatol. 2025. PMID: 40664380
201 results